The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter randomized phase II trial comparing nab-paclitaxel to paclitaxel in patients with advanced urothelial cancer progressing on or after a platinum containing regimen: NCIC Clinical Trials Group BL 12 (NCT02033993).
 
Srikala S. Sridhar
Honoraria - Astellas Pharma; Janssen Oncology
Consulting or Advisory Role - Sanofi
Research Funding - Janssen Oncology (Inst); Sanofi (Inst)
 
Normand Blais
No Relationships to Disclose
 
Scott A. North
Honoraria - Astellas Pharma; Janssen-Ortho; Novartis; Pfizer
 
Ben Tran
No Relationships to Disclose
 
Kim N. Chi
Honoraria - Astellas Pharma; Janssen; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; ESSA; Janssen; Lilly/ImClone; Sanofi; Takeda
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Exelixis (Inst); Janssen (Inst); Novartis (Inst); Oncogenex (Inst); Sanofi (Inst); Teva (Inst); Tokai Pharmaceuticals (Inst)
 
John W. Robinson
No Relationships to Disclose
 
M. Neil Reaume
Consulting or Advisory Role - GlaxoSmithKline; Janssen; Janssen; Novartis; Pfizer; Sanofi
Travel, Accommodations, Expenses - Novartis
 
Geoffrey Liu
Honoraria - novartis; pfizer
Consulting or Advisory Role - novartis; pfizer
Research Funding - roche (Inst)
 
Gail T McDonald
No Relationships to Disclose
 
Keyue Ding
No Relationships to Disclose
 
Wendy R. Parulekar
No Relationships to Disclose